Fosamprenavir or atazanavir once daily boosted with ritonavir 100mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

This publication has 21 references indexed in Scilit:

• Faculty Opinions recommendation of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
  Published by H1 Connect ,2013
• Tenofovir-Associated Fanconi Syndrome: Review of the FDA Adverse Event Reporting System
  AIDS Patient Care and STDs, 2008
• Greater Tenofovir‐Associated Renal Function Decline with Protease Inhibitor–Based versus Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Therapy
  The Journal of Infectious Diseases, 2008
• British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2006)
  HIV Medicine, 2006
• Treatment for Adult HIV Infection
  JAMA, 2006
• Pharmacokinetics of Tenofovir Disoproxil Fumarate and Ritonavir-Boosted Saquinavir Mesylate Administered Alone or in Combination at Steady State
  Antimicrobial Agents and Chemotherapy, 2006
• Lack of Pharmacokinetic Drug Interaction between Tenofovir Disoproxil Fumarate and Nelfinavir Mesylate
  Antimicrobial Agents and Chemotherapy, 2005
• Atazanavir
  Annals of Pharmacotherapy, 2004
• Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
• The effect of ritonavir on saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of pharmacokinetic data from 97 subjects
  HIV Medicine, 2002